Maria Carolina Sanabria-Salas
Overview
Explore the profile of Maria Carolina Sanabria-Salas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanabria-Salas M, Rivera-Herrera A, Manotas M, Guevara G, Gomez A, Medina V, et al.
Eur J Hum Genet
. 2025 Mar;
PMID: 40065011
Genetic studies in Latin America have expanded, but further efforts are needed to understand cancer susceptibility genes beyond BRCA1 and BRCA2, especially by characterizing the prevalence and spectrum of pathogenic...
2.
Sanabria-Salas M, Anggala N, Gillies B, Farncombe K, Hofstedter R, Peck L, et al.
BMC Cancer
. 2025 Jan;
25(1):176.
PMID: 39885482
Background: Integrating germline genetic testing (GGT) recommendations from tumor testing into hereditary cancer clinics and precision oncology trials presents challenges that require multidisciplinary expertise and infrastructure. While there have been...
3.
Sanabria-Salas M, Pedroza-Duran A, Diaz-Casas S, Nunez Lemus M, Grillo-Ardila C, Briceno-Morales X, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893140
This study aimed to investigate prognosis and survival differences in 82 breast cancer patients with germline pathogenic/likely pathogenic variants (PVs) treated and followed at the Breast Unit of the Instituto...
4.
Acosta-Vega N, Varela R, Mesa J, Garai J, Gomez-Gutierrez A, Serrano-Gomez S, et al.
Front Oncol
. 2024 Apr;
14:1338250.
PMID: 38634046
Background: African ancestry is a known factor associated with the presentation and aggressiveness of prostate cancer (PC). Hispanic/Latino populations exhibit varying degrees of genetic admixture across Latin American countries, leading...
5.
Hebert J, De Santis R, Daniyal L, Mannan S, Ng E, Thain E, et al.
Epilepsy Res
. 2024 Mar;
202:107336.
PMID: 38471245
Purpose: Studies have shown an increased risk of epilepsy in patients with neurofibromatosis type 1 (NF1). However, most reports focus on the pediatric population. In this study, we describe the...
6.
Huertas-Caro C, Ramirez M, Rey-Vargas L, Bejarano-Rivera L, Ballen D, Nunez M, et al.
Sci Rep
. 2023 Dec;
13(1):21324.
PMID: 38044375
Triple negative breast cancer (TNBC) is highly immunogenic and high levels of tumor infiltrating lymphocytes (TILs) have been associated with a better prognosis and higher probability to achieve pathological complete...
7.
Manotas M, Rivera A, Sanabria-Salas M
Mol Genet Genomic Med
. 2023 Mar;
11(5):e2141.
PMID: 36905130
Background: Variant curation refers to the application of evidence-based methods for the interpretation of genetic variants. Significant variability in this process among laboratories affects clinical practice. For admixed Hispanic/Latino populations,...
8.
Hofstedter R, Sanabria-Salas M, Di Jiang M, Ezzat S, Mete O, Kim R
Endocr Pathol
. 2023 Jan;
34(2):257-264.
PMID: 36701047
Adrenal cortical carcinoma is an aggressive and rare malignancy of steroidogenic cells of the adrenal gland. Most adult adrenal cortical carcinomas are sporadic, but a small fraction may be associated...
9.
Manotas M, Rivera A, Gomez A, Abisambra P, Guevara G, Medina V, et al.
Front Genet
. 2023 Jan;
13:999329.
PMID: 36685941
Pheochromocytomas (PCCs) and paragangliomas (PGLs) (known as PPGL in combination) are rare neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia. About 40% of the patients with PPGL have a...
10.
Rey-Vargas L, Bejarano-Rivera L, Mejia-Henao J, Sua L, Bastidas-Andrade J, Ossa C, et al.
Front Oncol
. 2023 Jan;
12:989761.
PMID: 36620598
Background: Our previous study reported higher mRNA levels of the human epidermal growth factor receptor 2 (HER2)-amplicon genes and in estrogen receptor (ER)-positive breast cancer patients with relatively high Indigenous...